We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPG
451
DELISTED
Interpublic Group of Companies
IPG
| $2.19M | 0.03% |
99,012
-6,927
| -7% | -$147K |
|
452
Sensata Technologies
ST
$6.65B
| $2.18M | 0.03% |
38,005
-23,984
| -39% | -$1.28M |
|
|
DF
453
DELISTED
Dean Foods Company
DF
| $2.17M | 0.03% |
131,458
+87,762
| +201% | +$1.51M |
|
454
Yum! Brands
YUM
$41B
| $2.16M | 0.03% |
38,165
-906,252
| -96% | -$49.5M |
|
|
RENT
455
DELISTED
RENTRAK CORP
RENT
| $2.16M | 0.03% |
+38,872
| New | +$2.44M |
|
|
RDUS
456
DELISTED
Radius Health, Inc.
RDUS
| $2.15M | 0.03% |
+52,233
| New | +$2.35M |
|
457
Armstrong World Industries
AWI
$6.86B
| $2.15M | 0.03% |
37,316
-15,705
| -30% | -$841K |
|
458
Sonoco
SON
$5.76B
| $2.14M | 0.03% |
47,104
+40,947
| +665% | +$1.85M |
|
459
Johnson & Johnson
JNJ
$635B
| $2.14M | 0.03% |
21,260
-112,218
| -84% | -$11.4M |
|
460
Zumiez
ZUMZ
$320M
| $2.11M | 0.03% |
+52,406
| New | +$2.03M |
|
|
HDS
461
DELISTED
HD Supply Holdings, Inc.
HDS
| $2.1M | 0.03% |
67,409
-204,175
| -75% | -$5.94M |
|
|
ATML
462
DELISTED
ATMEL CORP
ATML
| $2.09M | 0.03% |
254,001
+20,045
| +9% | +$168K |
|
|
LORL
463
DELISTED
Loral Space and Communications, Inc.
LORL
| $2.05M | 0.03% |
30,000
-1,800
| -6% | -$130K |
|
464
Rigel Pharmaceuticals
RIGL
$680M
| $2.04M | 0.03% |
57,295
+20,943
| +58% | +$574K |
|
|
ADMS
465
DELISTED
Adamas Pharmaceuticals
ADMS
| $2.03M | 0.03% |
+115,883
| New | +$1.99M |
|
|
SIX
466
DELISTED
Six Flags Entertainment Corp.
SIX
| $2.02M | 0.03% |
+41,786
| New | +$1.9M |
|
467
Gen Digital
GEN
$15.6B
| $2.01M | 0.03% |
86,198
+54,375
| +171% | +$1.36M |
|
|
JAH
468
DELISTED
JARDEN CORPORATION
JAH
| $2M | 0.03% |
+37,887
| New | +$1.91M |
|
|
QIHU
469
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $2M | 0.03% |
38,956
-126,198
| -76% | -$6.85M |
|
470
Intel
INTC
$466B
| $1.99M | 0.03% |
63,700
-136,814
| -68% | -$4.62M |
|
|
DNB
471
DELISTED
Dun & Bradstreet
DNB
| $1.93M | 0.03% |
+15,057
| New | +$1.89M |
|
|
DMK
472
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $1.92M | 0.03% |
6,959
+3,959
| +132% | +$1.71M |
|
473
Tapestry
TPR
$28.8B
| $1.91M | 0.02% |
46,099
-4,920
| -10% | -$196K |
|
|
SLXP
474
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $1.88M | 0.02% |
10,900
+8,065
| +284% | +$1.18M |
|
475
Designer Brands
DBI
$277M
| $1.88M | 0.02% |
51,036
+45,103
| +760% | +$1.65M |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.